TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/16/23 16:54 | 2/14/23 | MLYS | Mineralys Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Levy Adam Scott | PA | O | CFO,Chie | P | 100 | 16.00 | 0 | 6 | 2 | 351 | D | ||||||||||||||
2/13/18 17:02 | 2/13/18 | MGEN | Miragen Therapeutics, Inc. | DE | Health | Health | Medical Laboratories | Levy Adam Scott | CO | O | Chief Bu | P | 50 | 5.50 | 0 | 9 | 627 | 11 | D | ||||||||||||||
6/23/17 19:07 | 6/22/17 | MGEN | Miragen Therapeutics, Inc. | Health | Health | Medical Laboratories | Levy Adam Scott | CO | O | Chief Bu | P | 2 | 7.55 | 0 | 0 | New | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |